To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

The effect of growth horm… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.

Journal article
Authors Yrsa Bergmann Sverrisdóttir
Mikael Elam
Kenneth Caidahl
Ann-Sofi Söderling
Hans Herlitz
Gudmundur Johannsson
Published in Journal of hypertension
Volume 21
Issue 10
Pages 1905-14
ISSN 0263-6352
Publication year 2003
Published at Cardiovascular Institute
Institute of Clinical Neurosciences
Institute of Clinical Neurosciences, Section of Experimental Neuroscience
Institute of Internal Medicine, Dept of Body Composition and Metabolism
Pages 1905-14
Language en
Links dx.doi.org/10.1097/01.hjh.000008475...
www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Aged, Blood Pressure, Body Water, metabolism, Cardiac Output, Cross-Over Studies, Female, Glucose Tolerance Test, Hormone Replacement Therapy, Human Growth Hormone, administration & dosage, Humans, Hypopituitarism, drug therapy, physiopathology, Insulin-Like Growth Factor I, metabolism, Lipids, blood, Male, Middle Aged, Muscle, Skeletal, innervation, Nitric Oxide, metabolism, Sympathetic Nervous System, drug effects, physiopathology, Thyroid Hormones, blood, Vascular Resistance, Ventricular Function, Left
Subject categories Kidney diseases, Endocrinology

Abstract

To test whether sympathetic nerve hyperactivity associated with adult hypopituitarism and untreated growth hormone (GH) deficiency is affected by GH treatment.Sympathetic nerve activity to the muscle vascular bed (MSA) expressed as burst frequency (bursts/min) and incidence (bursts/100 heartbeats) was recorded in 10 hypopituitary patients (aged 48-69 years), before and after acute (1 week) randomized, double-blind, crossover treatment with a 1-month washout period and chronic (1 year) GH replacement treatment.MSA burst frequency and incidence remained unchanged from baseline values after the short-term treatment, but exhibited decreases in median values [from 53 to 47 bursts/min (P = 0.02) and from 85 to 70 bursts/100 heartbeats (P = 0.03), respectively] after 12 months of replacement therapy. Twenty-four-hour urinary excretion of nitrate increased after the short-term cross-over treatment and the long-term treatment (P = 0.04). Diastolic blood pressure and waist circumference decreased after the 12-month treatment (P = 0.02 and P = 0.04, respectively). No correlation was found between the reduction in MSA and the increase in 24-h urinary nitrate excretion, the decrease in diastolic blood pressure and waist circumference.The sympathoexcitation in adult GH deficiency and the modest decline in MSA seen after long-term GH replacement treatment may suggest that the somatotropic axis is involved in the regulation of central sympathetic outflow.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?